Commercial Pharmaceutical Analytics Market Research Report - Global Forecast till 2027

Global Commercial Pharmaceutical Analytics Market Research Report: Information by Type (Descriptive Analytics, Predictive Analytics and Prescriptive Analytics), Application (R&D, Marketing & Sales, Supply Chain Optimization and Internal Reporting), Deployment (On-Premise and Web-Based/Cloud-Based), Components (Software and Services) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/HCIT/0332-CR | August 2019 | Region: Global | 137 pages

The Global Commercial Pharmaceutical Analytics Market is expected to register 20.0% CAGR and is anticipated to reach USD 9,308.4 Million by 2027. 


Analytics is a tool for the mining of massive amounts of scattered data, processing the data to align it into useful information. This processed data can then be used in various processes. Analytics eases the workload in an organization and enables it to maintain an efficient workflow. Analytics can be implemented through multiple software services provided over web-based/client-based model and on-premise model. The pharmaceutical industry is witnessing a change as analytics is playing a pivotal role in helping the pharmaceutical and life-science industries in terms of sophistication of process and resulting business impact they create. While the adoption of analytics in the pharmaceutical industry is relatively new, third-party analytic business services are proliferating and are likely to grow even faster with increasing adoption rate in the future.


The growing adoption of new technologies and analytical tools, regulation of R&D productivity, the growing trend of the big data advertisement in pharma sector and increasing usage of analytical tools in streamlining the business process are the major drivers propelling market growth. However, the lack of skilled professionals and the conservative nature of the healthcare industry constrain the growth of the market.


Market Dynamics


More than 40% of the world’s population now have access to the internet. Internet is a vast space for people to source their data and get the desired information. More than 80% of the population with internet access search for the information about the disease and its treatment, drugs acting on it. People are becoming aware of online pharmaceutical information pools, which has created an enormous space for the pharmaceutical companies to broadcast their product information and pricing as well as their applications. It has become a great way of advertising without having to use physical media. Digital advertising is becoming very popular as it is proactive, with real time analysis, and, also, reaches wider audience.


Moreover, the recent explosive uptake of smartphones has also impacted hugely on the advertising media. Digital advertising uses analytical tools, including big data, which is helping the pharmaceutical companies in marketing their products and reaching a specific consumer pool, enhancing their business and increasing revenue opportunities. The increasing advertising opportunities expected to support the growth of the global commercial pharmaceutical analytics market.


Global Commercial Pharmaceutical Analytics Market Size, by Application, 2016 (USD Million)
 Commercial Pharmaceutical Analytics Market


Source: MRFR Analysis


Segmentation


The global commercial pharmaceutical analytics market has been segmented into type, application, deployment, components, and end user.


Based on type, the global market has been segmented into descriptive analytics, predictive analytics, and prescriptive analytics. Based on application, the global market has been segmented into R&D, marketing & sales, supply chain optimization, and internal reporting. The marketing & sales segment accounted for a market value of USD 231.4 million in 2016.  Based on Deployment, the global market has been divided on-premise and web-based/cloud-based. Based on components, the global market is divided into software and services.


Key Players


The prominent players in the global commercial pharmaceutical analytics market are Tata Consultancy Services Limited, IBM, ORACLE, Wipro, CitiusTech Inc., International Business Machines Corporation, Northwest Analytics, Inc., SCIO HEALTH ANALYTICS, Statistical Analysis System, TAKE Solutions Ltd, and TRINITY PHARMA SOLUTIONS.


Some of the key strategies followed by the players operating in the global commercial pharmaceutical analytics market are innovation, product development, acquisition, and expansion.


Asia-Pacific Commercial Pharmaceutical Analytics Market Share, by Country, 2016 (%)
 Commercial Pharmaceutical Analytics Market


Source: MRFR Analysis


Regional Analysis


The global commercial pharmaceutical analytics market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global commercial pharmaceutical analytics market during the forecast period. This is attributed to the dominating the commercial pharmaceutical analytics market in this region as it has deployed several commercial pharmaceutical analytics solutions and its application in various segments. The market for commercial pharmaceutical analytics in Europe is expected to be the second-largest during the forecast period. Due to the increasing demand of the pharmaceutical analytics technology, which widely utilizes the information for quantitative and subjective analysis, is experiencing an industry change from volume-based medicine and reimbursement to esteem-based medications and reimbursement. Additionally, the companies operating in the market are increasingly focusing on mergers and acquisitions, which is expected to support market growth during the forecast period. Asia-Pacific is estimated to be the fastest-growing market due to the presence of developing countries in this region that are adopting newer technologies for ease of work. The market for commercial pharmaceutical analytics in India offers high growth opportunities owing to the rising awareness of applications of new pharmaceutical analytics in untapped markets. Moreover, in Asia-Pacific, China accounted for a market share of 25% in 2016. The market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare facilities.


Key Updates



  • In June 2016, IBM Corp agreed to manage Blackboard Inc.’s datacenters



  • In June 2016, Pfizer selected Oracle Health Science for providing its cloud service and Oracle Siebel clinical trial management solutions to help manage and monitor its clinical trials.



  • June 2016, Chilmark Research incorporated SCIO Health Analytics in its organizations, driving the transition to 'Total Active Risk' model that enhanced patient outcomes and cut operational expenses.


Market Segmentation


Global Commercial Pharmaceutical Analytics Market, by Type



  • Descriptive Analytics

  • Predictive Analytics

  • Prescriptive Analytics


Global Commercial Pharmaceutical Analytics Market, by Application



  • R&D,

  • Marketing & Sales

  • Supply Chain Optimization

  • Internal Reporting


Global Commercial Pharmaceutical Analytics Market, by Deployment



  • On-Premise

  • Web-Based/Cloud-Based


Global Commercial Pharmaceutical Analytics Market, by Components



  • Software

  • Services


Global Commercial Pharmaceutical Analytics Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Additional Companies

    • Allscripts

    • Microsoft

    • Fuzzy Logix INC

    • Cerner Corporation



  • Challenges in the Global Commercial Pharmaceutical Analytics Market


Intended Audience



  • Medical device manufacturers and distributors

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies



Frequently Asked Questions (FAQ) :


Commercial pharmaceutical analytics market projected to grow at approximately 20.0% CAGR during the assessment period (2017-2023).

The valuation of the global commercial pharmaceutical analytics market is estimated to increase to USD 9,308.4 MN by the end of 2023.

Spurting rise in the pharmaceutical and life science industry and the adoption of analytics in these industries are major tailwinds pushing the growth of the global commercial pharmaceutical analytics market.

North America holds the largest share in the global commercial pharmaceutical analytics market, followed by Europe and the Asia Pacific, respectively.

International Business Machines Corporation, Wipro Limited CitiusTech Inc., Northwest analytics, Inc., Scio Health Analytics, Trinity Pharma Solutions, ORACLE, Statistical Analysis System, Tata Consultancy Services Limited, and TAKE Solutions Ltd., are some of the top players operating in the global commercial pharmaceutical analytics market.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

USD YEN EURO GBP INR
TABLE OF CONTENT

2.1 Definition 17

2.2 Scope of Study 18

2.2.1 Research Objective 18

2.2.2 Assumptions & Limitations 18

2.2.2.1 Assumptions 18

2.2.2.2 Limitations 18

2.3 Market Structure: 19

3.1 Introduction 20

3.2 Primary Research 21

3.3 Secondary research 21

3.4 Market Size Estimation 22

4.1 Drivers 24

4.1.1 Growing Adoption of New Technologies and Analytical Tools 24

4.1.2 Regulation of R&D Productivity 24

4.1.3 Growing Trend of the Big Data Advertisement in Pharma Sector. 25

4.1.4 Increasing Usage of Analytical Tools in Streamlining Business Process 25

4.2 Restraint 26

4.2.1 Lack of Skilled Professionals 26

4.2.2 Conservative Nature of Healthcare Industry. 26

5.1 Porter’s Five Forces Model 27

5.1.1 Introduction 27

5.1.2 Bargaining Power of Suppliers 28

5.1.3 Bargaining Power of BUYERS: 28

5.1.4 Intensity of Competitor’s: 28

5.1.5 Threat of New Entrants 29

5.1.6 Threat from Substitutes 29

5.2 Value Chain Analysis 30

5.2.1 Inputs 31

5.2.2 Developments Process 31

5.2.3 Output 31

5.2.4 Marketing and Distribution 31

5.2.5 Post Selling Services 31

6.1 Introduction 32

6.1.1 Descriptive Analytics 34

6.1.2 Predictive Analytics 34

6.1.3 Prescriptive Analytics 35

7.1 Introduction 37

7.2 R&D 39

7.2.1 Marketing & Sales 40

7.2.2 Supply Chain Optimization 40

7.2.3 Internal Reporting 41

10.1 Introduction 51

10.2 Americas 53

10.2.1 North America 57

10.2.1.1 US 59

10.2.1.2 Canada 61

10.2.2 Latin America 63

10.3 Europe 65

10.3.1 Western Europe 69

10.3.1.1 Germany 69

10.3.1.2 France 71

10.3.1.3 UK 73

10.3.1.4 Italy 75

10.3.1.5 Spain 77

10.3.1.6 Rest of Western Europe 79

10.3.2 Eastern Europe 81

10.3.3 Asia-Pacific 83

10.3.3.1 Japan 87

10.3.3.2 China 89

10.3.3.3 India 91

10.3.3.4 South Korea 93

10.3.3.5 Rest of Asia-Pacific 95

10.3.4 Middle East & Africa 97

11.1 Introduction 101

11.1.1 Mergers Acquisitions 102

11.1.2 Collaborations 103

11.1.3 Release/New Product Launches 103

11.1.4 Other (Expansion, Updates, Partnership) 104

12.1 CitiusTech Inc. 106

12.1.1 Company Overview 106

12.1.2 Product/Business Segment Overview 106

12.1.3 Financial Overview 106

12.1.4 Key Developments 106

12.2 International Business Machines Corporation 107

12.2.1 Company Overview 107

12.2.2 Product/Business Segment Overview 107

12.2.3 Financial Overview 108

12.2.4 Key Developments 109

12.3 Northwest analytics, Inc. 110

12.3.1 Company Overview 110

12.3.2 Product/Business Segment Overview 110

12.3.3 Financial Overview 110

12.3.4 Key Developments 110

12.4 ORACLE 111

12.4.1 Company Overview 111

12.4.2 Product/Business Segment Overview 111

12.4.3 Financial Overview 112

12.4.4 Key Developments 113

12.5 SCIO HEALTH ANALYTICS 114

12.5.1 Company Overview 114

12.5.2 Product/Business Segment Overview 114

12.5.3 Financial Overview 114

12.5.4 Key Developmentss 115

12.6 Statistical Analysis System 116

12.6.1 Company Overview 116

12.6.2 Product/Business Segment Overview 116

12.6.3 Financial Overview 117

12.6.4 Key Developments 118

12.7 TAKE Solutions Ltd 119

12.7.1 Company Overview 119

12.7.2 Product/Business Segment Overview 119

12.7.3 Financial Overview 120

12.7.4 Key Developmentss 121

12.8 Tata Consultancy Services Limited 122

12.8.1 Company Overview 122

12.8.2 Product/Business Segment Overview 122

12.8.3 Financial Overview 123

12.8.4 Key Developments 124

12.9 TRINITY PHARMA SOLUTIONS 125

12.9.1 Company Overview 125

12.9.2 Product/Business Segment Overview 125

12.9.3 Financial Overview 125

12.9.4 Key Developmentss 125

12.10 Wipro Limited 126

12.10.1 Company Overview 126

12.10.2 Product/Business Segment Overview 126

12.10.3 Financial Overview 127

12.10.4 Key Developments 128

13.1 Key Findings 129

TABLE 1 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 32

TABLE 2 GLOBAL DESCRIPTIVE ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 34

TABLE 3 GLOBAL PREDICTIVE ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 35

TABLE 4 GLOBAL PRESCRIPTIVE ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 36

TABLE 5 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY APPLICATION (USD MILLION) 2014–2027 37

TABLE 6 GLOBAL RESEARCH & DEVELOPMENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2014–2027 39

TABLE 7 GLOBAL MARKETING & SALES IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2014–2027 40

TABLE 8 GLOBAL SUPPLY CHAIN IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2014–2027 41

TABLE 9 GLOBAL INTERNAL REPORTING IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2014–2027 42

TABLE 10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 43

TABLE 11 ON PREMISE MODEL IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2014–2027 45

TABLE 12 WEB BASED/CLOUD BASED MODEL IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2014–2027 46

TABLE 13 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY COMPONENTS (USD MILLION) 2014–2027 47

TABLE 14 GLOBAL SOFTWARE COMPONENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2014–2027 49

TABLE 15 GLOBAL SERVICES COMPONENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION (USD MILLION) 2014–2027 50

TABLE 16 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 51

TABLE 17 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 54

TABLE 18 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 55

TABLE 19 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATONS (USD MILLION) 2014–2027 55

TABLE 20 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 56

TABLE 21 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 56

TABLE 22 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 57

TABLE 23 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 57

TABLE 24 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 58

TABLE 25 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2014–2027 58

TABLE 26 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 59

TABLE 27 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 59

TABLE 28 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 60

TABLE 29 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 60

TABLE 30 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 61

TABLE 31 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 61

TABLE 32 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 62

TABLE 33 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 62

TABLE 34 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 63

TABLE 35 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 63

TABLE 36 ATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 64

TABLE 37 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 64

TABLE 38 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 66

TABLE 39 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 67

TABLE 40 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 67

TABLE 41 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 68

TABLE 42 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 68

TABLE 43 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 69

TABLE 44 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 69

TABLE 45 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 70

TABLE 46 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 70

TABLE 47 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 71

TABLE 48 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 71

TABLE 49 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 72

TABLE 50 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 72

TABLE 51 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 73

TABLE 52 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 73

TABLE 53 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 74

TABLE 54 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 74

TABLE 55 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 75

TABLE 56 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 75

TABLE 57 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 76

TABLE 58 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 76

TABLE 59 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 77

TABLE 60 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 77

TABLE 61 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 78

TABLE 62 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 78

TABLE 63 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 79

TABLE 64 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 79

TABLE 65 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 80

TABLE 66 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 80

TABLE 67 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 81

TABLE 68 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 81

TABLE 69 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 82

TABLE 70 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 82

TABLE 71 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 84

TABLE 72 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 85

TABLE 73 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 85

TABLE 74 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 86

TABLE 75 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2014–2027 86

TABLE 76 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 87

TABLE 77 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 87

TABLE 78 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 88

TABLE 79 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2014–2027 88

TABLE 80 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 89

TABLE 81 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 89

TABLE 82 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 90

TABLE 83 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2014–2027 90

TABLE 84 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 91

TABLE 85 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 91

TABLE 86 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 92

TABLE 87 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2014–2027 92

TABLE 88 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 93

TABLE 89 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 93

TABLE 90 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 94

TABLE 91 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2014–2027 94

TABLE 92 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 95

TABLE 93 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 95

TABLE 94 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 96

TABLE 95 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT (USD MILLION) 2014–2027 96

TABLE 96 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 97

TABLE 97 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2014–2027 98

TABLE 98 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION (USD MILLION) 2014–2027 99

TABLE 99 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2014–2027 99

TABLE 100 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS (USD MILLION) 2014–2027 100

FIGURE 2 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY TYPE, 2016 (%) 14

FIGURE 3 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY APPLICATION, 2016 (%) 14

FIGURE 4 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY DEPLOYMENT, 2016 (%) 15

FIGURE 5 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY COMPONENT, 2016 (%) 15

FIGURE 6 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY REGION, 2016 (%) 16

FIGURE 7 RESEARCH PROCESS 20

FIGURE 8 FORECAST MODEL 23

FIGURE 9 VALUE CHAIN ANALYSIS 30

FIGURE 10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE (USD MILLION) 2016 & 2027 33

FIGURE 11 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY APPLICATION (USD MILLION) 2016 & 2027 38

FIGURE 12 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT (USD MILLION) 2016 & 2027 44

FIGURE 13 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY COMPONENTS (USD MILLION) 2014 & 2027 48

FIGURE 14 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 52

FIGURE 15 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 54

FIGURE 16 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 66

FIGURE 17 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 84

FIGURE 18 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION (USD MILLION) 2014–2027 98

FIGURE 19 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE ANALYSIS 2016 (%) 101

FIGURE 20 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET COMPETITIVE ANALYSIS 2016 (%) 102

FIGURE 21 RECENT FINANCIALS 108

FIGURE 22 GEOGRAPHIC REVENUE MIX, 2016 (%) 108

FIGURE 23 SEGMENTAL REVENUE MIX, 2016 (%) 109

FIGURE 24 RECENT FINANCIALS 112

FIGURE 25 GEOGRAPHIC REVENUE MIX, 2016 (%) 112

FIGURE 26 SEGMENTAL REVENUE MIX, 2016 (%) 113

FIGURE 27 RECENT FINANCIALS 117

FIGURE 28 GEOGRAPHIC REVENUE MIX, 2016 117

FIGURE 29 SEGMENTAL REVENUE MIX, 2016 118

FIGURE 30 RECENT FINANCIALS (USD MILLION) 120

FIGURE 31 GEOGRAPHIC REVENUE MIX, 2016 (%) 120

FIGURE 32 SEGMENTAL REVENUE MIX, 2016 (%) 121

FIGURE 33 RECENT FINANCIALS 123

FIGURE 34 GEOGRAPHIC REVENUE MIX, 2016 (%) 123

FIGURE 35 SEGMENTAL MIX, 2016 (%) 124

FIGURE 36 RECENT FINANCIALS 127

FIGURE 37 GEOGRAPHIC REVENUE MIX, 2016 (%) 127

FIGURE 38 SEGMENTAL REVENUE MIX, 2016 (%) 128